PROVIDED BY HTTP://CNNNEXT.COM Published on Oct 7, 2015 The dangers of prescription drugs are mostly well-known, but most people believe that their over the
Watch Video

#dc#dc comics#batman#tim drake#bruce wayne#batfamily#dick grayson#batfam#dc fanart




seen from Malaysia
seen from China

seen from United States
seen from Malaysia

seen from Malaysia

seen from Italy
seen from T1

seen from United Kingdom
seen from T1
seen from Germany
seen from China
seen from Germany

seen from Malaysia
seen from China
seen from United States
seen from Malaysia
seen from Saudi Arabia
seen from Malaysia
seen from China
seen from United States
PROVIDED BY HTTP://CNNNEXT.COM Published on Oct 7, 2015 The dangers of prescription drugs are mostly well-known, but most people believe that their over the
Watch Video
PROVIDED BY HTTP://CNNNEXT.COM Published on Aug 17, 2015 A blockbuster diabetes drug called Invokana has pulled in hundreds of millions of dollars for Big Pha
FDA Regulation of Molecular Diagnostics
There is a lot of confusion regarding the process for obtaining approval for commercial use of molecular diagnostics by FDA and reimbursement by the payers. The development steps, testing requirements prior to approval, role of CMS and FDA in certifying the tests and testing location, and scientific basis for approval vary from test to test. There is very little guidance from the FDA stating its expectations from a given test leading to the regulatory pathways being customized on a case-by-case basis. This webinar will answers the above questions providing practical tips to comply with FDA’s requirements.
This webinar is intended for general instructions to all molecular diagnostic providers such as laboratories, clinics, physicians, hospitals, reimbursement experts, clinical trial users, and regulators who wish to have a better understanding of how FDA regulate such tests. Register here